180 Life Sciences Rövid arány
Mi az 180 Life Sciences Rövid arány?
A Rövid arány az 180 Life Sciences Corp. - 6.78
Mi a Rövid arány meghatározása?
A rövid arány az értékesített részvények rövid száma, az átlagos napi mennyiséggel elosztva.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Rövid arány a Health Care szektor a NASDAQ-on cégekben a 180 Life Sciences -hoz képest
Mit csinál 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
rövid arány -hoz hasonló cégek 180 Life Sciences
- Avid Technology nak Rövid arány 6.76 van
- Greenwich LifeSciences nak Rövid arány 6.76 van
- Aldeyra Therapeutics Inc nak Rövid arány 6.76 van
- Consolidated Communications Inc nak Rövid arány 6.77 van
- Omnicell nak Rövid arány 6.77 van
- Spire nak Rövid arány 6.77 van
- 180 Life Sciences nak Rövid arány 6.78 van
- Independent Bank Inc nak Rövid arány 6.79 van
- Electra Battery Materials Corp nak Rövid arány 6.79 van
- Assembly Biosciences Inc nak Rövid arány 6.79 van
- NanoViricides Inc nak Rövid arány 6.79 van
- Park Hotels & Resorts Inc nak Rövid arány 6.79 van
- Tennant Co nak Rövid arány 6.79 van